654655-75-1

Basic information

• Product Name: 1-Propanone, 3-[methyl(phenylmethyl)amino]-1-(1-naphthalenyl)-
• CAS NO: 654655-75-1
• Molecular Formula: C21H21NO
• Molecular Weight: 303.404
• Mol File: 654655-75-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 1-Propanone, 3-[methyl(phenylmethyl)amino]-1-(1-naphthalenyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Propanone, 3-[methyl(phenylmethyl)amino]-1-(1-naphthalenyl)-(654655-75-1)
• EPA Substance Registry System: 1-Propanone, 3-[methyl(phenylmethyl)amino]-1-(1-naphthalenyl)-(654655-75-1)

Safety Data

• Hazardous Substances Data: 654655-75-1(Hazardous Substances Data)

Upstream product

• 654655-69-3 3-benzyl-6-bromo-2-methoxyquinoline 
• 345949-37-3 3-chloro-1-(naphthalen-1-yl)-propan-1-one 
• 103-67-3 benzyl-methyl-amine 
• 941-98-0 1'-naphthacetophenone 
• 50-00-0 formaldehyd 

Downstream Products

• 861709-20-8 C₃₈H₃₅BrN₂O₂ 

Relevant articles and documents

PROTEIN CROSSLINKING INHIBITOR AND USE OF THE SAME

The present invention relates to: a ketone compound having transglutaminase-inhibiting activity, which is represented by the following Formula 1, 2, or 3: wherein R1 is a substituted or unsubstituted aryl or heterocyclyl group, R2, R3, and R4 are hydrogen atoms, n is 2, X is halogen, R5 and R6 independently represent a hydrogen atom or a substituted or unsubstituted C1-C10 alkyl, aryl, or aralkyl group, wherein R5 and R6 are not hydrogen atoms at the same time, or R5 and R6 may be taken together to form a saturated or unsaturated and substituted or unsubstituted heterocyclyl group containing a nitrogen atom (N); an inhibitor of protein crosslinking comprising the compound; and a composition for preventing or treating a protein-crosslinking causative disease, which comprises the compound or the protein crosslinking inhibitor.

QUINOLINE DERIVATIVES AS ANTIBACTERIAL AGENTS

Use of a compound for the manufacture of a medicament for the treatment of a bacterial infection provided that the bacterial infection is other than a Mycobacterial infection, said compound being a compound of Formula (Ia) or (Ib), a pharmaceutically acce

SUBSTITUTED QUINOLINES AND THEIR USE AS MYCOBACTERIAL INHIBITORS

The present invention relates to novel substituted quinoline derivatives according to the general formula (Ia) or the general formula (Ib) salts, quaternary amines, stereochemically isomeric forms, tautomeric forms and N--oxide forms thereof, wherein Rsu